000			01077nam a22002537a 4500
003			OSt
005			20240305192523.0
008			220801b |||||||| |||| 00| 0 eng d
020			_a0824722280
040			_cDLC
082			_a 616.99449061 ING
100			_aJames N. Ingle _940960
245			_aAdvances in endocrine therapy of breast cancer _b proceedings of the 2003 Gleneagles Conference
260			_aNew York _bMarcel Dekker _bSummit Communications _cc2004.
300			_a xv, 317 p. : ill. (some col.) ;, 24 cm. _bIncludes bibliographical references and index.
600			_x Breast--Cancer--Endocrine aspects--Congresses. _940961
600			_x Selective estrogen receptor modulators--Congresses. _940962
600			_x Antineoplastic Agents, Hormonal--therapeutic use--Congresses. _940963
600			_xBreast Neoplasms--drug therapy--Congresses. _940964
600			_x Breast Neoplasms--prevention & control--Congresses. _940965
600			_xChemotherapy, Adjuvant--methods--Congresses. _940966
700			_aMitchell Dowsett. _940967
942			_2ddc _cEB
999			_c7939 _d7939